Skip to content

IPS Gate® integration drives KLS Martin’s delivery of 500 LCM printed bioceramic implants

Share this article

LinkedInFacebookXWhatsAppE-mail

3D ADEPT · AUDIO

Listen to this article

4 min

Narrated using a synthetic voice.

Craniofacial models and blue and beige bioceramic implants.
KLS Martin_Zygomatic Onlay Implant_made from Hydroxyapatite_Green Part_Sintere

KLS Martin Group manufactures surgical instruments, implants, and medical devices. By the end of Q3 2026, it expects to reach 500 delivered individual bioceramic implants.

The milestone relies on IPS Gate®, the company’s web-based platform for planning, ordering, and delivering its Individual Patient Solutions (IPS®). The case-planning app supports custom-made implants produced from various materials using a variety of technologies.

Frank Reinauer, Senior Director Division Implant, KLS Martin: “Individual-Patient-Specific (IPS®) ß-TCP status on IPS Gate® means a broad availability; surgeons can plan, specify, and order a patient-specific bioceramic implant through the same digital workflow they already use for our other IPS® solutions. That shortens the path from CT data to a case-specific, tailored-porosity scaffold in a surgeon’s hands, which translates directly into faster treatment planning and more predictable delivery timelines for patients that rely on bone-regenerating implants.”

Among the key products of the platform, there are patient-specific 3D-printed implants made with Lithoz’s calcium phosphate material LithaBone TCP.

Johannes Homa, Lithoz CEO: “Launching LithaBone TCP implants as  an official product on IPS Gate® marks a true milestone for bioceramic 3D printing in surgery. What began 12 years ago as a research collaboration with KLS Martin has grown into a proven clinical pathway with scalable solutions. Seeing the success KLS Martin is having with our technology, as well as the general global adaptation of LCM in MedTech, shows that resorbable, additively manufactured bone-regenerating solutions are gaining broader clinical acceptance worldwide and demonstrate the growing role of additively manufactured bioceramic solutions in regenerative medicine.”

The manufacturing process of LithaBone TCP implants

To manufacture these implants, the KLS team relies on Lithography-based Ceramic Manufacturing (LCM) 3D printers. It operates under an ISO 13485 certified quality management system.

LCM enables biomedical and engineering teams to produce patient‑specific geometries and controlled porosities. These therefore directly influence how the scaffold degrades and how new, healthy bone replaces it.

Beyond traditional fixation with titanium screws, KLS Martin’s SonicWeld Rx® system can also secure the implants. It uses resorbable polymer pins. As a result, the fully resorbable implant assembly can avoid a separate operation to remove the fixation hardware.

Resorbable, patient‑specific solutions are now entering routine practice. We therefore can’t wait to discover how far ceramic additive manufacturing will reshape the standard of care in cranio‑maxillofacial reconstruction.

Read more about how Lithoz’ LCM is used in the healthcare and medical industries

Source: Lithoz — KLS Martin and IPS Gate, 16 September 2026.

Source: KLS Martin — resorbable osteosynthesis.

THE 3D ADEPT WEEKLY NEWSLETTER

The industry moves fast. Stay ahead.

Every week, the latest additive manufacturing news, in-depth features and real-world applications, straight to your inbox. Plus, be the first to know when a new issue of 3D ADEPT Mag is out.

Free · One email a week · Unsubscribe anytime

Clicking loads our email provider’s sign-up form, including its analytics and Google’s anti-bot protection. You’re only subscribed if you complete the sign-up. Read our privacy policy.

Open the form in a new tab ↗

Share this article

LinkedInFacebookXWhatsAppE-mail

The weekly newsletter

Essential AM knowledge, delivered weekly.

News, in-depth features and industry perspectives, in your inbox.

Receive the newsletter